Abiopharma

Guardant Health’s Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families

BioVie Inc. - BioVie Completes Enrollment in Phase 2 SUNRISE-PD Trial in Early Parkinson’s Disease

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of Americas Most Successful Small-Cap Companies

CoyaTherapeutics - Coya Therapeutics Announces Results of Investigator-Initiated Study of LD IL-2 and CTLA4-Ig Demonstrating Treg Enhancement and Cognitive Stability in Frontotemporal Dementia Patients

Halozyme - Halozyme Announces Global Collaboration and License Agreement with Takeda to Develop and Commercialize Vedolizumab withENHANZE®

Ecolab Inc. - Ecolab Earns Double ‘A’ Rating from CDP for Leadership in Water and Climate Performance

Reviva Announces Publication on Clinical Vocal Biomarker Data from the RECOVER Phase 3 Clinical Trial of Brilaroxazine to Treat Negative Symptoms in Schizophrenia

GRI Bio Announces Additional Positive Data from Phase 2a Study in Idiopathic Pulmonary Fibrosis, Strengthening Clinical Proof-of-Concept for GRI-0621

Revolution Medicines Announces FDA Breakthrough Therapy Designation for Zoldonrasib

Collegium Provides 2026 Financial Guidance and Business Update